Skip to main content icon/video/no-internet

THE UNIVERSITY OF California, Davis (UCD), is a public research university, the main campus of which is located in Davis, California, near Sacramento; the UCD Medical School is located in Sacramento. It is one of 10 universities within the University of California system and was the third branch of the University of California. It began in 1905 as an agricultural school known as the university farm. UCD became a general campus within the University of California system in 1959; this includes the UC Davis School of Medicine, which was founded in 1966. In 2006, UCD enrolled over 23,000 undergraduate and 4,000 graduate and 2,900 professional students and employed over 10,000 academic staff members including almost 2,500 faculty members and over 20,000 support staff members.

The Stem Cell Program at UCD is a multidis—ciplinary enterprise involving faculty members and researchers from the school of medicine and other parts of the university, including biological sciences, veterinary medicine, engineering, business, law, and bioethics. The program's overarching goal is to develop stem cell therapies to prevent, treat, or cure human diseases. This goal will be realized through three types of activities, as detailed on the program's Web page: performance of detailed comparisons of adult stem cells, and those from a variety of age groups, with human embryonic stem cells differentiated toward defined lineages using animal models of health and disease, including immunodeficient mice, small and large animal models, and nonhuman primate models; facilitation and enhancement of collaborations between basic, translation, and clinical faculty members in disease—specific focus groups; and the performance of high—quality, basic and translational research leading to clinical trials for stem and progenitor cell—mediated tissue repair and regeneration. Researchers in the program currently (in 2007) work with adult stem cells but may some day include embryonic stem cells as well, when questions of safety and efficacy are resolved.

Stem Cell Center

A new facility to house the UCD Stem Cell Center is expected to be completed in downtown Sacramento, near the UCD Medical Center, in September 2008. It will include laboratory and support space, a shared vector core, an immunodeficient mouse/toxicology vivarium and microscopy core, a cell sorter core, and space for offices, training, and conference rooms. The new facility will also house a Good Manufacturing Practice facility, which will play an important role in the center's goal of facilitating movement of the cellular therapies studied in animal models into human clinical trials.

UCD physicians and researchers have been in the forefront of stem cell research, a fact attested to by their success in attracted funding. In 2005, UCD was named by the National Institutes of Health as one of only two Centers of Excellence for translational human stem cell research in the United States; the new center created with this funding is called the Center for Pédiatrie Stem and Progenitor Cell Translational Research. In addition, UCD received one of the first grants bestowed by the California Institute for Regenerative Medicine (CIRM), a state agency that disburses funds for stem cell research, raised by a bond issue and private donations, to establish a research and training program for young scientists. UCD also received multiyear research grants totaling about $8 million from CIRM in 2007 and an additional $2.8 million in capital construction grants.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading